SCHEMBL2321932

SCHEMBL2321932

O=C(c1c2c(nc3ccccc13)CCN(Cc1ccnc(Cl)c1)C2)N1CCOCC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ TP53 P04637 1/20 0.50
▸ KMT2A Q03164 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ LMNA P02545 5/20 0.48
▸ MAPT P10636 3/20 0.47
▸ POLB P06746 2/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ HTT P42858 2/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ NPC1 O15118 2/20 0.45
▸ RAB9A P51151 2/20 0.45
▸ GAA P10253 1/20 0.45
▸ PDE5A O76074 1/20 0.41
▸ TSHR P16473 1/20 0.40
▸ PIK3CD O00329 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2320640 0.89 ALDH1A1 (0.60) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL2322324 0.84 ALDH1A1 (0.49) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL26454872 0.81 MAPT (0.61) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL2445770 0.80 LMNA (0.43) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL2450732 0.80 PIK3CD (0.46) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL2318728 0.78 KMT2A (0.62) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL2320616 0.77 ALDH1A1 (0.41) ALDH1A1MAPK1TP53LMNAMAPT
SCHEMBL2322493 0.76 LMNA (0.45) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL12301216 0.76 LMNA (0.43) ALDH1A1MAPK1TP53KMT2AMEN1
SCHEMBL2445695 0.76 LMNA (0.47) ALDH1A1MAPK1TP53KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2011-09-22 — — US disclosed
EP-2352733-A1 BENZONAPHTYRIDINE COMPOUNDS USED AS INHIBITORS OF AUTOTAXIN Merck Patent GmbH (DE) 2011-08-10 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230471-A1 BENZONAPHTYRIDINE COMPOUNDS AS INHIBITORS OF AUTOTAXIN ENPP2, TPX2, TPD52L2 ALDH1A1 4584/4885MAPK1 3988/4885TP53 262/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback